Comment from CHPA

Summary: The Consumer Healthcare Products Association (CHPA) opposes the petition to remove diphenhydramine from the OTC Cough, Cold, Allergy Monograph. They argue that diphenhydramine is a safe, effective, and widely used medication with a unique therapeutic role that lacks one-for-one substitutes, and that its removal would negatively impact consumer access and public health.